Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients

Journal of Cystic Fibrosis

Volumn 12, Issue 6, 2013, Pages 662-666

  Vanderhelst, Eef ^a   De Wachter, Elke ^a   Willekens, Julie ^a   Piérard, Denis ^a   Vincken, Walter ^a   Malfroot, Anne ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; CLINDAMYCIN; FUSIDIC ACID; PSEUDOMONIC ACID; RIFAMPICIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL STRAIN; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CYSTIC FIBROSIS; DIARRHEA; DISEASE ERADICATION; DRUG TREATMENT FAILURE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMAN; INFANT; MEDICATION COMPLIANCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NAUSEA; OBSERVATIONAL STUDY; OINTMENT; PRESCHOOL CHILD; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SPIROMETRY; TOPICAL TREATMENT; VOMITING;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYSTIC FIBROSIS; DISEASE ERADICATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFANT; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MUPIROCIN; NASAL MUCOSA; NUCLEIC ACID SYNTHESIS INHIBITORS; OINTMENTS; PROSPECTIVE STUDIES; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84888071700     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.04.009     Document Type: Article

References (24)

1. US National CF Patient Registry 2008.
2. 1 decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-centre, case control study of 165 patients. J Cyst Fibros 2012 Jan, 11(1):2-7.
3. Seybold U., Kourbatova E.V., Johnson J.G., Halvosa S.J., Wang Y.F., King M.D., et al. Emergence of community-associated methicillin resistant Staphylococcus aureus USA300 genotype as a major cause of health-care associated blood stream infections. Clin Infect Dis 2006, 42(5):647-656.
4. 1 decline in cystic fibrosis. Am J Respir Crit Care Med 2008, 178(8):814-821.
5. Dasenbrook E.C., Checkley W., Merlo C.A., Konstan M.W., Lechtzin N., Boyle M.P. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 2010 Jun 16, 303(23):2386-2392.
6. Ren C.L., Morgan W.J., Konstan M.W., Schechter M.S., Wagener J.S., Fisher K.A., et al. Presence of methicillin-resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol 2007, 42(6):513-518.
7. Sawicki G.S., Rasouliyan L., Pasta D.J., Regelmann W.E., Wagener J.S., Waltz D.A., et al. The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis. Pediatr Pulmonol 2008 Nov, 43(11):1117-1123. [PubMed PMID: 18846559]. 10.1002/ppul.20914.
8. Labandeira-Rey M., Couzon F., Boiseet S., Brown E.L., Bes M., Benito Y., et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007, 315(5815):1130-1133.
9. Givney R., Vicjery A., Holliday A., Pegler M., Benn R. Methicillin-resistant Staphylococcus aureus in a cystic fibrosis unit. J Hosp Infect 1997, 35(1):27-36.
10. Tarzi S., Kennedy P., Stone S., Evans M. Methicillin-resistant Staphylococcus aureus: psychological impact of hospitalization and isolation in an older adult population. J Hosp Infect 2001 Dec, 49(4):250-254.
11. McCaffery K., Olver R.E., Franklin M., Mukhopadhyay S. Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis. Thorax 1999, 54(5):380-383.
12. Macfarlane M., Leavy A., McCaughan J., fair R., Reud A.J. Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis using a three-step protocol. J Hosp Infect 2007, 65(3):231-236.
13. Solis A., Brown D., Hughes J., Van Saene H.K., Heaf D.P. Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: an eradication protocol. Pediatr Pulmonol 2003, 36(3):189-195.
14. Maiz L., Canton R., Mir N., Baquero F., Escobar H. Aerosolized vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. Pediatr Pulmonol 1998, 26(4):287-289.
15. Serisier D.J., Jones G., Carol M. Eradication of pulmonary methicillin-resistant Staphylococcus aureus in cystic fibrosis with linezolid. J Cyst Fibros 2004, 3(1):61.
16. Garske L.A., Kidd T.J., Gan R., Bunting J.P., Franks C.A., Coulter C., et al. Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus isolation in adults with cystic fibrosis and chronic MRSA infection. J Hosp Infect 2004, 56(3):208-214.
17. Ferrin M., Zuckerman J.B., Meagher A., Blumberg E.A. Successful treatment of methicillin-resistant Staphylococcus aureus pulmonary infection with linezolid in a patient with cystic fibrosis. Pediatr Pulmonol 2002, 33(3):221-223.
18. Kappler M., Felicke M., Schweiger-Kabesch Schroter C., Liese J., Ripper J., et al. Eradication of methicillin-resistant Staphylococcus aureus in cystic fibrosis. J Cyst Fibros 2009, 8. [abstract 170].
19. UK Cystic Fibrosis Trust Infection Control Working Group Methicillin-resistant Staphylococcus aureus 2008.
20. Vergison A., Denis O., Deplano A., Casimir G., et al. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients. J Antimicrob Chemother 2007, 59:893-899.
21. Doe S.J., McSorley A., Isalka B., Kearns A.M., et al. Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres. J Cyst Fibros 2010, 9:104-109.
22. Lamer C., de Beco V., Soler P., Calvat S., Fagon J.Y., Dombret M.C., et al. Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrob Agents Chemother 1993 Feb, 37(2):281-286.
23. Legout L., Senneville E., Gomel J.J., Yazdanpanah Y., Mouton Y. Linezolid-induced neuropathy. Clin Infect Dis 2004 Mar 1, 38(5):767-768. [PubMed PMID: 14986270].
24. Endimiani A., Blackford M., Dasenbrook E.C., Reed M.D., Bajaksouszian S., Hujer A.M., et al. Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland Ohio. Antimicrob Agents Chemother 2011 Apr, 55(4):1684-1692.